Synageva Biopharma Corp (NASDAQ:GEVA)

Add to Watch List

Set Alert

41.56 Data as of Jun 18	0.00 / 0.00% Today’s Change	36.45 Today\|\|\|52-Week Range 58.00	-10.22% Year-to-Date

41.56

Data as of Jun 18

0.00 / 0.00%

Today’s Change

36.45

Today|||52-Week Range

58.00

-10.22%

Year-to-Date

SECTOR

Health Technology

INDUSTRY

Biotechnology

MARKET CAP

$1.1B

Company Description

Synageva BioPharma Corp. is a clinical stage biopharmaceutical company, which engages in discovering, developing and delivering therapies for patients with rare conditions and unmet medical need. The company engages in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1996 and is headquartered in Lexington, MA.

Contact Information

Synageva BioPharma Corp.

128 Spring Street

Lexington Massachusetts 02421

P:(781) 357-9900

Investor Relations:
(781) 357-9900

www.synageva.com

Employees

Shareholders

Mutual fund holders	47.90%
Other institutional	46.24%
Individual stakeholders	44.55%

Top Executives

Sanj K. Patel	President, Chief Executive Officer & Director
Carsten Boess	Chief Financial Officer & Senior Vice President
Mark Alan Goldberg, MD	Senior Vice President-Medical & Regulatory Affairs
Anthony G. Quinn, MD, PhD	Chief Medical Officer & Senior Vice President
Sandra Rojas	VP-Clinical Research & Exploratory Development

To view my watchlist

Not a member yet?

jobs by

Search for jobs

Search All Jobs from Across the Web

About CNNMoney
Content
Magazines
Site Tools
Stay Connected
- My Account
- Mobile Site & Apps
- Facebook
- Twitter
- LinkedIn
- YouTube
- RSS Feeds
- Newsletters
- Tumblr
- Google+

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones Indexes^SM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones Indexes^SM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.